HIV/STI Unit, Institute of Tropical Medicine, Antwerp, Belgium.
Division of Infectious Diseases and HIV Medicine, University of Cape Town, Observatory, South Africa.
Microb Drug Resist. 2020 Sep;26(9):1063-1070. doi: 10.1089/mdr.2019.0497. Epub 2020 Mar 17.
Previous studies evaluating the cultural and structural factors underpinning the large variations in the consumption of antibiotics in high-income countries have reached different conclusions. Some studies have found that corruption plays a dominant role, whereas other studies have concluded that cultural factors such as the degree of uncertainty avoidance (UA) and performance-orientation versus cooperation-orientation (POCO) are more important. These studies have been limited to Europe, and we, therefore, aimed to expand this analysis to all high-income countries with available data. Using antibiotic consumption data from the IQVIA MIDAS database, linear regression models were constructed with country-level cephalosporin, fluoroquinolone, and macrolide consumption (defined daily doses/1,000 population/year) as the outcome variables and country-specific scores of UA and POCO (obtained from the Hofstede Index), gross domestic product/capita, world region and markers of effective governance (Control of Corruption and Regulatory Quality extracted from the World Bank data) as the explanatory variables. All data, excluding the Hofstede Indices, used country-level averages for the years 2013 to 2015. Complete data were available for 37 countries from 4 world regions. Consumption of cephalosporins, macrolides, and fluoroquinolones was associated with POCO and UA, but not the markers of effective governance. In the case of macrolide consumption, the association with UA narrowly missed statistical significance. Repeat analyses limited to first European countries and second to non-European countries revealed similar findings. More thought should be given to construct antibiotic stewardship campaigns that are tailored to the local extent of UA and POCO.
先前评估高收入国家抗生素消费差异的文化和结构因素的研究得出了不同的结论。一些研究发现腐败起主导作用,而其他研究则得出结论认为不确定性规避程度(UA)和绩效导向与合作导向(POCO)等文化因素更为重要。这些研究仅限于欧洲,因此,我们旨在将这种分析扩展到所有具有可用数据的高收入国家。
使用 IQVIA MIDAS 数据库中的抗生素消费数据,我们构建了线性回归模型,以国家层面的头孢菌素、氟喹诺酮和大环内酯类抗生素消费(定义为每日剂量/每千人/年)为因变量,以国家特定的 UA 和 POCO 评分(从 Hofstede 指数获得)、人均国内生产总值、世界区域和有效治理指标(从世界银行数据中提取的腐败控制和监管质量)为解释变量。除了 Hofstede 指数外,所有数据均使用 2013 年至 2015 年的国家层面平均值。
来自 4 个世界区域的 37 个国家提供了完整的数据。头孢菌素、大环内酯类和氟喹诺酮类药物的消费与 POCO 和 UA 相关,但与有效治理指标无关。在大环内酯类药物消费方面,与 UA 的关联略低于统计学意义。仅限于欧洲第一类国家和非欧洲第二类国家的重复分析得出了类似的发现。
应更多地考虑构建适合当地 UA 和 POCO 程度的抗生素管理活动。